| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 621.870 | 253.905 | 238.451 | 677.359 | 460.391 | 565.049 | 465.913 | 193.098 |
| Total Income - EUR | - | - | 621.870 | 253.910 | 238.459 | 680.169 | 460.419 | 565.176 | 492.687 | 193.101 |
| Total Expenses - EUR | - | - | 78.336 | 253.058 | 215.607 | 643.817 | 450.368 | 382.676 | 780.029 | 101.906 |
| Gross Profit/Loss - EUR | - | - | 543.535 | 851 | 22.852 | 36.353 | 10.051 | 182.500 | -287.341 | 91.195 |
| Net Profit/Loss - EUR | - | - | 542.015 | 823 | 21.168 | 34.760 | 9.680 | 154.190 | -287.341 | 76.887 |
| Employees | - | - | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Quadrifoglio Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 612 | 698 | 88.992 | 150.317 | 254.716 | 275.866 | 351.679 | 209.998 |
| Current Assets | - | - | 642.143 | 746.885 | 617.664 | 454.029 | 758.818 | 1.189.952 | 1.687.110 | 905.092 |
| Inventories | - | - | 7 | 6 | 7 | 182.105 | 130.272 | 60.226 | -337 | 3.137 |
| Receivables | - | - | 536.524 | 580.336 | 376.415 | 203.768 | 419.003 | 557.915 | 1.597.653 | 795.860 |
| Cash | - | - | 105.613 | 166.543 | 241.243 | 68.095 | 209.543 | 537.837 | 15.949 | 32.663 |
| Shareholders Funds | - | - | 542.058 | 542.990 | 553.643 | 505.550 | 504.019 | 659.773 | 370.431 | 445.248 |
| Social Capital | - | - | 44 | 10.100 | 9.904 | 9.717 | 9.501 | 9.531 | 9.502 | 9.449 |
| Debts | - | - | 100.697 | 204.592 | 159.347 | 68.734 | 509.515 | 806.044 | 1.668.357 | 669.842 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Quadrifoglio Medical Srl